Best Turmeric Supplements: Curcuminoids, Forms, Prices and the Liver Warning

Turmeric is the root and the spice. Supplement extracts concentrate its curcuminoids, often to a stated percentage such as 95%.

Curcuminoids are the three main compounds: curcumin, demethoxycurcumin, and bisdemethoxycurcumin. A label that says “95% curcuminoids” on a 500 mg extract has 475 mg of curcuminoids. That is arithmetic, not a lab test of a bottle.

Absorption is why brands add pepper or change the form. Curcumin is poorly absorbed on its own. In a 1998 report, 20 mg of piperine raised curcumin’s bioavailability in people by 2,000% [10]. It was a very small study. A phospholipid form, Meriva, produced about 29-fold more total curcuminoids in blood than the unformulated mixture in a crossover study, and the blood levels stayed below those used in lab experiments [11]. Blood levels are not outcomes. No study on this page shows that a form works better for a human outcome.

Why we flag absorption: NCCIH says highly bioavailable formulations of curcumin may harm the liver [1]. Better absorption is not automatically better.

We are not recommending a brand, and this draft does not print a price table. Named product columns are held until those picks are decided. What you can compare on any label, today, is the form.

These are trial results in the people who were studied, mostly people with knee pain scores. They are not a promise about a capsule, and they are not advice for a joint condition.

Wang 2021 [5]: 16 randomized trials of turmeric extracts, 1,810 adults, up to 16 weeks. Knee-pain scores were lower than placebo (standardized mean difference −0.82) and similar to NSAID comparators. Heterogeneity was high (I² 86%), risk of bias was moderate, and the authors note uncertainty because the studies were short and varied.

Feng 2022 [6]: 15 studies of curcuminoids alone, 1,670 patients. Pain scores on a visual analog scale were lower than placebo by 1.77 points on average, and adverse events were not more frequent than placebo. The authors cite low quality and substantial heterogeneity and recommend a “cautious and conservative” approach.

Hsiao 2021 [7]: 11 studies, 1,258 participants. No significant difference in pain or adverse events between 1,000 mg a day or more and lower doses.

Liu 2018 [8]: 69 trials of 20 osteoarthritis supplements. Curcuma longa extract and curcumin were among seven supplements with large short-term pain effects. The overall quality of evidence across the supplement set was very low, and no supplement had clinically important effects on pain at long-term follow-up.

Henrotin 2019 [9]: 150 people with knee osteoarthritis, 3 months, a branded “bio-optimized” Curcuma longa extract at two doses versus placebo. Pain fell by 29.5 mm and 36.5 mm versus 8 mm with placebo. A cartilage biomarker did not differ between groups. More product-related adverse events occurred in the high-dose group. One author affiliation is Tilman SA, and the trial registration names FLEXOFYTOL. It tested one commercial product.

Not shown: NCCIH, updated April 2025, says “we don’t know enough” to conclude that turmeric or curcumin is beneficial for any health purpose [1].

Piperine is the compound in black pepper that raised curcumin absorption in the 1998 human report [10]. It was also in some supplements linked to liver-injury reports. In the DILIN case series, chemical analysis confirmed turmeric in all 7 products tested, and 3 of those 7 also contained piperine [2]. That does not show pepper caused harm. It is on this page so you can see pepper on a label and decide with a clinician.

NCCIH says conventionally formulated oral turmeric is likely safe for up to 2 or 3 months, and that highly bioavailable formulations may harm the liver. It says liver damage has been reported in some people who took those formulations. Stop and talk with a clinician if you notice fatigue, nausea, poor appetite, dark urine, or jaundice [1].

Halegoua-DeMarzio 2023, U.S. Drug-Induced Liver Injury Network [2]: 10 turmeric-associated cases enrolled 2004–2022, all since 2011. Eight of 10 were women. Median age 56. Five were hospitalized and one died of acute liver failure. Seven carried HLA-B*35:01 (allele frequency 0.450 versus 0.056–0.069 in population controls). The authors describe a latency of 1 to 4 months and say the rise may reflect usage patterns or more combination with black pepper. This is a case series. It shows an association. It does not say how common the injury is.

Likhitsup 2024 [3]: an NHANES analysis estimated about 15.6 million U.S. adults used at least one of six botanicals with reported liver liability in the past 30 days. Turmeric-containing products were the most commonly used of the six. It is an exposure survey, not an injury count.

USP 2026 review [4]: the expert committee’s recommended label caution, quoted from the paper: “Liver problems have been reported very rarely in people taking supplements containing turmeric and/or curcuminoids. Consult your health-care practitioner before using this product if you have a history of liver problems. Stop using this product if you develop symptoms such as abdominal pain, dark urine, or jaundice (yellowing of the skin or eyes), and seek medical advice.”

We could not open the NIH LiverTox turmeric page in a browser on October 28, 2026, so this guide does not quote an incidence figure or a “most common cause” line from that page.

Medicines. NCCIH does not name blood thinners specifically. It says to talk with your provider if you take any medicine [1]. A 10-day study of one phytosome product (Meriva) found no significant change in bleeding time or INR in people already on aspirin, clopidogrel, ticlopidine, warfarin, or dabigatran [12]. The abstract does not state the funder. It was short, it tested one product, and it does not show safety for other products or longer use. Ask your prescriber before combining.

Pregnancy. NCCIH says turmeric supplements may be unsafe in pregnancy, and that little is known about doses above food amounts while breastfeeding [1].

Product-related side effects. In the 150-person Henrotin trial, the number of product-related adverse events was higher in the high-dose group than in placebo [9]. The Feng 2022 meta-analysis found no increase in adverse events versus placebo overall [6].

Quality. Ask for a lot-specific certificate of analysis that tests lead. We are not making a contamination claim about any brand.